Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk

Eur J Intern Med. 2024 Jan:119:39-41. doi: 10.1016/j.ejim.2023.10.030. Epub 2023 Nov 3.
No abstract available

Keywords: Atrial fibrillation; Chronic kidney disease; Dialysis; End-stage renal disease; NOACs; Oral anticoagulants.

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Kidney Failure, Chronic* / complications
  • Kidney Failure, Chronic* / drug therapy
  • Stroke* / drug therapy
  • Thromboembolism* / prevention & control

Substances

  • Anticoagulants